Thomas F Whayne. Show Affiliations »
Abstract
Mesh： See more » Coronary Disease/prevention & controlHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsMuscular Diseases/chemically inducedNonprescription DrugsPatient CompliancePatient Education as TopicPatient ParticipationPrimary PreventionRisk AssessmentSafety
Substances： See more » Hydroxymethylglutaryl-CoA Reductase InhibitorsNonprescription Drugs
Year: 2008 PMID： 18308034 DOI： 10.1016/j.amjcard.2007.09.112
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778